Patent attorney Devan V. Padmanabhan is quoted in MedCity News about the Supreme Court’s Prometheus decision. Some people in the biotech industry are upset that the “natural bodily responses to medical treatment are not patent eligible” with the recent Supreme Court decision. Devan indicates that it would be “an overstatement to think that innovation in the diagnostics industry is going to suffer simply because of a single Supreme Court decision.”
To read the entire article, click here.
Parmar, Arundhati. “Two views: Diagnostics firms may be worried but there are write arounds.” MedCity News. 27 Mar. 2012.